Nprl3 is required for normal development of the cardiovascular system
- 669 Downloads
C16orf35 is a conserved and widely expressed gene lying adjacent to the human α-globin cluster in all vertebrate species. In-depth sequence analysis shows that C16orf35 (now called NPRL3) is an orthologue of the yeast gene Npr3 (nitrogen permease regulator 3) and, furthermore, is a paralogue of its protein partner Npr2. The yeast Npr2/3 dimeric protein complex senses amino acid starvation and appropriately adjusts cell metabolism via the TOR pathway. Here we have analysed a mouse model in which expression of Nprl3 has been abolished using homologous recombination. The predominant effect on RNA expression appears to involve genes that regulate protein synthesis and cell cycle, consistent with perturbation of the mTOR pathway. Embryos homozygous for this mutation die towards the end of gestation with a range of cardiovascular defects, including outflow tract abnormalities and ventriculoseptal defects consistent with previous observations, showing that perturbation of the mTOR pathway may affect development of the myocardium. NPRL3 is a candidate gene for harbouring mutations in individuals with developmental abnormalities of the cardiovascular system.
KeywordsGene Ontology Ventricular Septal Defect Ventricular Septal Defect mTOR Pathway Erythroid Cell
This work was supported by Marie Curie RTN EUrythron (MRTN-CT-2004-005499 to MSK), European Molecular Biology Organisation (ALT 325-2008 to LSP), Medical Research Council [Chris P. Ponting (C.P.P.) laboratory and Douglas R. Higgs (D.R.H.) laboratory], and the National Institute of Health Biomedical Research Centre Programme (D.R.H.) laboratory. We thank Dr. Taavi Neklesa for critically reading the manuscript. Thanks to Liz Ormondroyd from the Department of Cardiovascular Medicine (John Radcliffe Hospital, Oxford, UK) for collecting patients for the study. We also thank Pik-Shan Li, Christina Rode, and Sue Butler for assistance with transgenic lines production, breeding, and genotyping. We thank the patients for participation in this study.
Conflict of interest
The authors have no conflicts of interests to declare.
- Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, Sabatini DM (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11:859–871PubMedCrossRefGoogle Scholar
- Hughes JR, Cheng JF, Ventress N, Prabhakar S, Clark K, Anguita E, De Gobbi M, de Jong P, Rubin E, Higgs DR (2005) Annotation of cis-regulatory elements by identification, subclassification, and functional assessment of multispecies conserved sequences. Proc Natl Acad Sci USA 102:9830–9835PubMedCrossRefGoogle Scholar
- Lower KM, Hughes JR, De Gobbi M, Henderson S, Viprakasit V, Fisher C, Goriely A, Ayyub H, Sloane-Stanley J, Vernimmen D et al (2009) Adventitious changes in long-range gene expression caused by polymorphic structural variation and promoter competition. Proc Natl Acad Sci USA 106:21771–21776PubMedCrossRefGoogle Scholar
- Maciukenas M (1994) Treetool 2.0.2Google Scholar
- Nagy A, Gertsenstein M, Vintersten K, Behringer R (2003) Manipulating the mouse embryo: a laborartory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring HarborGoogle Scholar